Register for a Clinical Trial

Protocol GSK 201159
Title A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-Daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis
Phase II
Area Stomach
Indication

Diabetic Gastropoparesis

Treatment

Camicinal vs placebo

Requirement
Trial:
Your First Name:
Your Last Name:
Phone Number:
Address:
City:
State:
ZIP Code:
E-mail Address:
Cancel